AI Verdict
NATH has stronger fundamentals based on our AI analysis.
NATH vs NAMSW Fundamental Comparison
| Metric | NATH | NAMSW |
|---|---|---|
| Revenue | $127.0M | $22.5M |
| Net Income | $17.2M | $-203.8M |
| Net Margin | 13.6% | -905.7% |
| ROE | N/A | -29.8% |
| ROA | 33.8% | -26.5% |
| Current Ratio | 2.73x | 7.88x |
| Debt/Equity | N/A | 0.00x |
| EPS | $4.17 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NATH vs NAMSW: Frequently Asked Questions
Is NATH or NAMSW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NATH has stronger fundamentals. NATH is rated HOLD (42% confidence) while NAMSW is rated STRONG SELL (88% confidence). This is not investment advice.
How does NATH compare to NAMSW fundamentally?
NATHANS FAMOUS, INC. has ROE of N/A vs NewAmsterdam Pharma Co N.V.'s -29.8%. Net margins are 13.6% vs -905.7% respectively.
Which stock pays higher dividends, NATH or NAMSW?
NATH has a dividend yield of N/A or no dividend while NAMSW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NATH or NAMSW for long term?
For long-term investing, consider that NATH has HOLD rating with 42% confidence, while NAMSW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NATH vs NAMSW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NATH vs NAMSW, the AI consensus favors NATH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.